Streetbeat News

Revenues

APPS

Digital Turbine faces significant financial challenges, including declining revenues, negative margins, and shareholder dilution. The company's high debt and negative cash flow contribute to a weak balance sheet, making a turnaround unlikely in the near term. Despite a low price-to-sales multiple, these risks do not support a higher valuation.

Portfolio Pulse from

November 08, 2024 | 3:15 pm

CPRI

Capri Holdings reported a decline in second-quarter revenues and earnings due to weaker global demand for luxury fashion. The company's gross margin also decreased year over year.

Portfolio Pulse from

November 08, 2024 | 3:15 pm

ED

Consolidated Edison (ED) reported third-quarter earnings that exceeded the Zacks Consensus Estimate by 7.7%, with revenues also surpassing estimates by 1.9%.

Portfolio Pulse from

November 08, 2024 | 3:00 pm

MELI

MercadoLibre's stock recently dipped 15% due to missing EPS estimates and a drop in EBIT margin, despite strong revenue growth and solid operational performance. The company's growth story remains credible, supported by market share gains and expansion opportunities, though competition and economic cyclicality pose risks.

Portfolio Pulse from

November 08, 2024 | 3:00 pm

GPRO

GoPro's Q3 earnings and revenues exceeded expectations despite lower unit sales. However, a delayed camera launch could negatively impact revenues in 2024.

Portfolio Pulse from

November 08, 2024 | 3:00 pm

CLBT

Cellebrite faces potential risks that could impact its growth, including a CEO transition and possible federal budget cuts. Despite a 27% revenue increase and strong product adoption, these uncertainties lead to a neutral rating.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

AOSL

The LED Driver IC market is projected to reach USD 16.05 billion by 2032, driven by the demand for energy-efficient lighting solutions, smart city expansion, and increased use in automotive and residential sectors.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

SOLV

Solventum's Q3 earnings and sales exceeded estimates, driven by pricing normalization and increased demand for MedSurg products. The company also raised its 2024 outlook.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

BLBD

BlueBird (BLBD) is considered a strong buy with a $91 target due to its monopoly on alternative-fueled buses and significant revenue growth potential. The company has a competitive edge with its propane and gasoline buses, meeting new EPA standards and offering lower ownership costs. BlueBird's financial health is strong, with record profits, zero debt, and a government grant to increase production capacity by 40% in two years.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

MYGN

Myriad Genetics (MYGN) reported strong third-quarter earnings and revenue growth, driven by its Pharmacogenomics and Prenatal segments. The company has also raised its full-year EPS guidance for 2024.

Portfolio Pulse from

November 08, 2024 | 2:45 pm